Over 14 years of applied pharmaceutical company experience
Computational ( in silico ) drug discovery, QSAR and pharmacophore application, systems biology applied to pathway and biomarker discovery, in vitro methods, drug-drug interactions and computational ADME/TOX.
Successfully obtained NIH SBIR phase I and II grant funding as a principal investigator at different companies.
Valuable start-up company experience leading and managing teams of international scientists and collaborators, directing technology development and scientific research .
Ekins S , Kaneko T, Lipinski CA, Bradford J, Dole K, Spektor A, Gregory K, Blondeau D, Ernst S, Yang J, Goncharoff N, Hohman M and Bunin BA, Analysis and hit filtering of a very large library of compounds screened against Mycobacterium tuberculosis, Mol BioSyst In Press 2010.
Rishi R. Gupta, Gifford, EM, Liston T, Waller CL, Hohman M, Bunin BA and Ekins S , Using open source computational tools for predicting human metabolic stability and additional ADME/Tox properties, Drug Metab Dispos, In Press, 2010.
Ekins S and Williams EJ, When Pharmaceutical Companies Publish Large Datasets: An Abundance of riches or fool’s gold?, Drug Disc Today, In Press 2010.
Ekins S , Gupta R, Gifford E, Bunin BA, Waller CL, Chemical Space: missing pieces in cheminformatics, Pharm Res, In Press 2010.
Kortagere S, Krasowski MD, Reschly EJ, Venkatesh M, Mani S and Ekins S , Evaluation of Computational Docking to Identify PXR Agonists in the ToxCastTM Database Env Health Perspect, In Press 2010.
Ekins S , Honeycutt JD and Metz JT, Evolving molecules using multi-objective optimization: applying to ADME/Tox, Drug Disc Today, 15: 451-460, 2010.
Arnold RJG and Ekins S , Time for cooperation in health economics among the modeling community, PharmacoEconomics, 28(8):609-613, 2010.
Ekins S . and Williams AJ, Reaching out to collaborators: crowdsourcing for pharmaceutical research, Pharm Res, 27: 393-395, 2010.
Ekins S and Williams AJ, Precompetitive Preclinical ADME/Tox Data: Set It Free on The Web to Facilitate Computational Model Building to Assist Drug Development. Lab On A Chip, 10: 13-22, 2010.
Zientek M, Stoner C, Ayscue R, Klug-McLeod J, Jiang Y, West M, Collins C and Ekins S , Integrated In Silico- In vitro strategy for addressing Cytochrome P450 3A4 time dependent inhibition, Chem Res Toxicol, 23: 664-676, 2010.
Ekins S , Bradford J, Dole K, Spektor A, Gregory K, Blondeau D, Hohman M and Bunin BA, A Collaborative Database and Computational Models for Tuberculosis Drug Discovery, Mol BioSyst, 6: 840-851, 2010.
Associate Editor: Journal of Pharmacological and Toxicological Methods, since Jan 2001
Editorial Board: Drug Metabolism and Disposition, since 2003, Drug Discovery Today, since 2005, The Open Drug Delivery Journal 2007-2009, Current Drug Metabolism 2007-2009, Drug Metabolism Letters since 2007-2009. Pharmaceutical Research (Editor of Reviews) since 2009, Mutation Research-Reviews since 2009, The ChemSpider Journal of Chemistry 2009.
2R44GM069124-02 In Silico Assessment of Drug Metabolism and Toxicity, SBIR phase II (principal investigator) Funded (~$750,000 total cost) from 08/01/05 to 08/01/07.
1R43NS061376-01 Targeted Aggregation Inhibitors for the Treatment of Amyloid Diseases, SBIR phase I (principal investigator) Funded ($124,425 total cost) from 10/01/07 to 03/31/2008
1R43CA130183-01A1 Computer-Aided Design, Synthesis, And Testing Of A Novel Family Of Triazole-Based Anticancer Therapeutics, SBIR phase I (principal investigator) Funded (Total cost $114,818) From 05/01/08- 10/31/08
1R43AI078763-01A1 Development of an Inhibitor of Toxoplasma gondii, NIAID Advanced Technology SBIR (principal investigator on proposal submitted then replaced upon leaving company) Funded (Total cost $638,000)
1R41AI088893-01 Identification of novel therapeutics for tuberculosis combining cheminformatics, diverse databases and logic based pathway analysis, STTR phase I (Principal Investigator) Funded (Total cost $149,382) 07/01/11 – 06/30/11
Part of the consortia for the framework grant More Medicines for Tuberculosis
Specific Programme “Cooperation” – Theme "Health"